Control systems and decision making for antibody production

CC Goodnow, CG Vinuesa, KL Randall, F Mackay… - Nature …, 2010 - nature.com
This paper synthesizes recent progress toward understanding the integrated control systems
and fail-safes that guide the quality and quantity of antibody produced by B cells. We focus …

T‐cell subsets in the germinal center

RR Ramiscal, CG Vinuesa - Immunological reviews, 2013 - Wiley Online Library
T cells are known to migrate to B‐cell‐enriched follicles and germinal centers within
secondary lymphoid organs to provide help to B cells. Cognate T: B interactions that take …

Global analyses of human immune variation reveal baseline predictors of postvaccination responses

JS Tsang, PL Schwartzberg, Y Kotliarov, A Biancotto… - Cell, 2014 - cell.com
A major goal of systems biology is the development of models that accurately predict
responses to perturbation. Constructing such models requires the collection of dense …

Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial

CO Bingham III, RJ Looney, A Deodhar… - … : Official Journal of …, 2010 - Wiley Online Library
Objective To examine immunization responses in patients with rheumatoid arthritis (RA)
treated with rituximab and to investigate the effects of rituximab‐induced CD20+ B cell …

APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa

B Huard, T McKee, C Bosshard… - The Journal of …, 2008 - Am Soc Clin Investig
The bone marrow constitutes a favorable environment for long-lived antibody-secreting
plasma cells, providing blood-circulating antibody. Plasma cells are also present in mucosa …

Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment

J Wang, J Lozier, G Johnson, S Kirshner… - Nature …, 2008 - nature.com
Lysosomal storage diseases are characterized by deficiencies in lysosomal enzymes,
allowing accumulation of target substrate in cells and eventually causing cell death. Enzyme …

Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment

YKO Teng, EWN Levarht, M Hashemi… - … : Official Journal of …, 2007 - Wiley Online Library
Abstract Objective Anti‐CD20–mediated B cell depletion with rituximab is a new and
effective therapy for rheumatoid arthritis (RA). Although B cells in peripheral blood (PB) are …

The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases

N Cooper, DM Arnold - British journal of haematology, 2010 - Wiley Online Library
Depletion of B lymphocytes using the anti‐CD20 monoclonal antibody rituximab has wide‐
spread use in the treatment of patients with autoimmune disorders. As haematopoietic …

Characterization of proposed human B-1 cells reveals pre-plasmablast phenotype

K Covens, B Verbinnen, N Geukens… - Blood, The Journal …, 2013 - ashpublications.org
Controversy has arisen about the nature of circulating human CD20+ CD27+ CD43+ CD70−
CD69− B cells. Although originally described as being the human counterpart of murine B-1 …

Abnormalities of B cell subsets in patients with systemic lupus erythematosus

T Dörner, AM Jacobi, J Lee, PE Lipsky - Journal of immunological methods, 2011 - Elsevier
The prototypic autoimmune disease, SLE, is known to be associated with polyclonal B cell
hyperreactivity. Developing an understanding of the complex nature of human B cell …